首页|Guizhou Provincial People’s Hospital Reports Findings in Pancreatoduodenectomy ( Clinical efficacy of enhanced recovery surgery in Da Vinci robot-assisted pancre atoduodenectomy)
Guizhou Provincial People’s Hospital Reports Findings in Pancreatoduodenectomy ( Clinical efficacy of enhanced recovery surgery in Da Vinci robot-assisted pancre atoduodenectomy)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Surgery - Pancreatoduo denectomy is the subject of a report. According to news reporting originating in Guizhou, People’s Republic of China, by NewsRx journalists, research stated, “D a Vinci robot-assisted pancreaticoduodenectomy offers advantages, including mini mal invasiveness, precise, and safe procedures. This study aimed to investigate the clinical effectiveness of implementing enhanced recovery after surgery (ERAS ) concepts in Da Vinci robot-assisted pancreaticoduodenectomy.” The news reporters obtained a quote from the research from Guizhou Provincial Pe ople’s Hospital, “A retrospective analysis was conducted on clinical data from 6 2 patients who underwent Da Vinci robotassisted pancreaticoduodenectomy between January 2018 and December 2022. Among these patients, 30 were managed with ERAS principles, while 32 were managed using traditional perioperative management pr otocols. Surgical time, intraoperative blood loss, postoperative oral intake tim e, time to return of bowel function, time to ambulation, visual analog scale (VA S) pain scores, fluid replacement volume, length of hospital stay, total hospita l expenses, complications, and patient satisfaction were recorded and compared b etween the two groups. Postoperative follow-up included assessment of postoperat ive functional scores, reoperation rates, SF-36 quality of life scores, and surv ival rates. The average follow-up time was 35.6 months (range: 12-56 months). Th ere were no statistically significant differences in general characteristics, in cluding age, surgical time, intraoperative blood loss, and preoperative medical history between the two groups (P > 0.05). Compared to t he control group, the intervention group had an earlier postoperative oral intak e time, faster return of bowel function, rapid ambulation, and shorter hospital stays (P <0.05). The intervention group also had lower pos toperative VAS scores, lower fluid replacement volume, lower total hospital expe nses, and a lower rate of complications (P <0.05). Patient satisfaction was higher in the intervention group (P <0.0 5). There were no statistically significant differences between the two groups i n two-year functional scores, reoperation rates, quality of life scores, and sur vival rates (P > 0.05). Implementing ERAS principles in Da Vinci robot-assisted pancreaticoduodenectomy substantially expedited postoper ative recovery, lowered pain scores, and diminished complications.”
GuizhouPeople’s Republic of ChinaAsi aDigestive System Surgical ProceduresEmerging TechnologiesGastroenterologyHealth and MedicineHospitalsMachine LearningPancreasPancreaticoduodene ctomyPancreatoduodenectomyRobotRoboticsSurgery
NETL
NSTL
